Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): March 5, 2008

AMERICAN VANGUARD CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware   001-13795   95-2588080
(State or other jurisdiction of incorporation)   Commission File Number   (I.R.S. Employer Identification No.)

4695 MacArthur Court

Newport Beach, California 92660

(Address of principal executive offices)

Registrant’s telephone number: (949) 260-1200

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


Item 2.02 Results of Operations and Financial Condition

On March 5, 2008 American Vanguard Corporation issued a press release announcing its financial results for the quarter and year ended December 31, 2007. The full text of that press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information contained in this Current Report on Form 8-K, including the Exhibits attached hereto, is being furnished under Items 2.02 and 8.01 and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

 

Item 8.01 Other Events

On March 5, 2008, American Vanguard Corporation issued a press release announcing that it had completed the acquisition of substantially all of the assets of the production facility located in Marsing, Idaho (the “Marsing Facility”) and owned by Bayer Cropscience LP. The full text of that press release is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit 99.1    Press release dated March 5, 2008 of American Vanguard Corporation concerning fourth quarter and full year financial results for the period ended December 31, 2007.
Exhibit 99.2    Press release dated March 5, 2008 of American Vanguard Corporation concerning the completion of the acquisition of the Marsing Facility.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, American Vanguard Corporation has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    AMERICAN VANGUARD CORPORATION
Date: March 10, 2008     By:   /s/ Timothy J. Donnelly
        Timothy J. Donnelly
        Vice President, General Counsel & Secretary


INDEX TO EXHIBITS

 

Exhibit No.

  

Description

Exhibit 99.1    Press release dated March 5, 2008 of American Vanguard Corporation concerning fourth quarter and full year financial results for the period ended December 31, 2007.
Exhibit 99.2    Press release dated March 5, 2008 of American Vanguard Corporation concerning the completion of the acquisition of the Marsing Facility.